Here, through systematic characterization of regulated cell death pathway availability in treatment-naïve SCLC, we identify the non-NE subtype to be exquisitely ferroptosis sensitive while we find the NE subtype to be selectively vulnerable to TRX pathway inhibition. The gene discussed is TXN; the disease is small cell lung carcinoma.